Lantheus Holdings (LNTH) Could Be 7% Undervalued As Its Pipeline Story Builds

Lantheus Holdings (LNTH) has attracted attention after recent share price moves, with the stock near US$99.99 and its year-to-date total return materially ahead of its performance over the past three months.

Short term price action for Lantheus Holdings has softened, with the share price edging lower over the past quarter, even as the year-to-date share price return remains strongly positive. The 1-year total shareholder return of 77.41% indicates that longer term momentum has been far stronger than recent trading suggests.

Scan beyond Lantheus Holdings and line up other potential momentum candidates using our hand picked list of 33 high quality undervalued stocks in similar market conditions.

Lantheus Holdings now trades near US$99.99 after a strong year and a softer quarter. The question is whether that recent cooling leaves enough upside to justify the risks as the valuation section unfolds.

Most Popular Narrative: 7% Undervalued

Lantheus Holdings is framed as modestly undervalued, with a narrative fair value of about $107.74 compared with the recent $99.99 close. This places execution on its PET and neurology platform under the spotlight.

The portfolio broadening into new radiodiagnostics and radiotherapeutics, with BRAVNETSA now approved for GEP NETs and late stage assets such as OCTEVY, LNTH-2513 GP1 and LNTH-2401 in development, introduces additional potential revenue streams and creates opportunities for mix driven support to margins over time.

See why 79 investors see Lantheus Holdings as 7% undervalued.

Result: Fair Value of $107.74 (UNDERVALUED)

Still, the Lantheus Holdings story can be knocked off course if PSMA PET pricing pressure bites harder than expected or if further regulatory or manufacturing setbacks delay key products.

Find out about the key risks to this Lantheus Holdings narrative.

Next Steps

If this mix of optimism and risk around Lantheus Holdings feels finely balanced, consider acting promptly and stress testing the numbers yourself. To see what upbeat factors others are focusing on, review the 4 key rewards.

Looking for more investment ideas beyond Lantheus Holdings?

Do not stop your research with Lantheus Holdings. Use the Simply Wall St screener to line up fresh stocks that fit the kind of portfolio you actually want.

• Target steadier journeys by checking out companies with stronger defensive traits through the 32 resilient stocks with low risk scores.
• Hunt for potential mispricings by scanning our universe of 33 high quality undervalued stocks that pair quality fundamentals with attractive valuations.
• Unearth future contenders early by running through the 20 high quality undiscovered gems that many investors may not be watching yet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com